Danish company signs pact with Sanofi
What begun as a project funded by the Danish Advanced Technology Foundation is now receiving international attention, as it has captured the attention and wallet of French drug company, Sanofi.
by Stefan Singh Kailay
The Danish contract research organisation, Gubra, has struck a development deal with Novo Nordisk’s French rival on the diabetes market, Sanofi.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
CRO-CEO: Outsourcing is all talk, no action
For abonnenter
Company behind satiety pill is looking for partners
For abonnenter
Millions for the search of satiety pill
For abonnenter
